Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs Cipher Mining Inc (CIFR) Price & Performance

Amphastar Pharmaceuticals IncTrade
Cipher Mining IncTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs Cipher Mining Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Cipher Mining Inc trades at $18.05 (market cap $6.78B). The key difference: Cipher Mining Inc is far larger — about 7.8× Amphastar Pharmaceuticals Inc's market cap, and Cipher Mining Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

AMPHCIFR
Market Cap
$863.95M$6.78B
Sector
HealthBasic Materials
52-Week High
$30.81$29.18
52-Week Low
$16.87$4.72
Enterprise Value
$1.26B$11.53B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amphastar Pharmaceuticals Inc

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

Cipher Mining Inc

Cipher Digital (CIFR) trades at $17.18, down 5.66% amid bearish technical signals and recent earnings misses. The company is transitioning from Bitcoin mining to AI data center operations, with significant negative profitability metrics including -585.75% net income margin and -170.77% ROE. Recent news highlights accelerated HPC delivery and project financing progress while the stock faces valuation concerns with P/S of 34.3 and EV/EBITDA of 54.24.

Despite unanimous analyst buy ratings and a $31.78 consensus target, CIFR faces substantial execution risks in its business pivot. The transition requires massive capital investment with negative cash flows, while current valuation appears stretched relative to financial performance. The stock's near-term trajectory depends on successful AI revenue ramp-up and project execution.

Returns comparison

Trailing returns across standard periods

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About Cipher Mining Inc

Cipher Mining is an industrial-scale technology company focused on Bitcoin mining infrastructure. It develops and operates data centers in the US designed to strengthen the Bitcoin network and support decentralized finance.

Read more on CIFR